- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT05169047
Onderdrempel SCS of BMT (TRADITION)
De holistische respons van patiënten met aanhoudend ruggenmergpijnsyndroom type II door ruggenmergstimulatie onder de drempelwaarde in vergelijking met de beste medische behandeling, onderzocht door een multicentrische, gerandomiseerde, gecontroleerde studie
Given the substantial socioeconomic impact of Spinal Cord Stimulation (SCS) implantations and given that currently no direct high-quality evidence with a relevant outcome measurement is available to guide the treatment choice between subthreshold SCS versus best medical treatment in patients with Persistent Spinal Pain Syndrome Type 2 (PSPS-T2), we here propose a scientifically well-constructed randomized controlled trial to answer this question.
The primary scientific objective is to examine whether subthreshold SCS, compared to best medical treatment, provided to patients with PSPS-T2 results in a higher percentage of clinical holistic responders at 6 months. The secondary objective of the study is to examine if subthreshold SCS compared with BMT is having more efficacy in improving patients' individual competencies for self-management, increasing the likelihood to return to work, work status and healthcare expenditure, improving pain relief, obtaining pain medication reduction, decreasing anxiety and depression, increasing quality of life and decreasing disability.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
After filling in the questionnaires at the 6 months follow-up visit, patients could change treatment groups (in both directions). This decision will be a shared decisions between patient and treating physician in case the randomized intervention did not provided enough pain relief.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Jette, België, 1090
- Universitair Ziekenhuis Brussel
-
Mechelen, België
- Emmaüs, AZ Sint-Maarten
-
Roeselare, België
- AZ Delta
-
Turnhout, België
- AZ Turnhout
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Persistent Spinal Pain Syndrome Type II (PSPS-T2)
- Chronic pain as a result of PSPS-T2 that exists for at least 6 months with a pain intensity of at least 4/10 on the Numeric Rating Scale, refractory to conservative treatment.
- PSPS-T2 patients eligible for subthreshold SCS
- Age > 18 years
- Patient has been informed of the study procedures and has given written informed consent
- Patient willing to comply with study protocol including attending the study visits
Exclusion Criteria:
- Expected inability of patients to receive or properly operate the spinal cord stimulation system
- Evidence of an active psychiatric disorder
- Suffering from another chronic illness characterised by chronic generalized widespread pain (e.g. rheumatoid arthritis, fibromyalgia, chronic fatigue syndrome, scleroderma).
- Pregnancy
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Beste medische behandeling
|
For each patient who is randomized to BMT, an optimal individual treatment plan will be developed by the treating physician. |
|
Actieve vergelijker: Onderdrempelige stimulatie van het ruggenmerg
|
SCS will be programmed at subthreshold stimulation. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Clinical holistic responder status
Tijdsspanne: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
The clinical holistic responder status as a composite measure represents the global effect of a treatment, based on a combination of questionnaires. |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Overall pain intensity with Visual Analogue Scale (VAS)
Tijdsspanne: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Overall pain, defined as a combination of back and leg pain, but not pain from other body parts, measured with the VAS (100mm) |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Pain medication use
Tijdsspanne: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Open question regarding the dosage, frequency and type of pain medication |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Functional disability
Tijdsspanne: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
The functional disabilities will be assessed with the Oswestry Disability Index (ODI) |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Health related quality of life
Tijdsspanne: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Health related quality of life, evaluated with the EuroQol with five dimensions and 5 levels |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Patient global impression of change
Tijdsspanne: Evaluated at 1 month, 6 months and 12 months.
|
Patients will be asked to quantify the impression of change after treatment using the Patient Global Impression of Change scale (PGIC). |
Evaluated at 1 month, 6 months and 12 months.
|
|
Work status
Tijdsspanne: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Work status is evaluated with a self-designed questionnaire |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Patients' individual competencies for self-management
Tijdsspanne: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Patient activation measure-13 (PAM) is a 13-item instrument which assesses self-reported behaviour, knowledge, and confidence for self-management of one's health. |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Healthcare utilisation.
Tijdsspanne: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Healthcare expenditure will be investigated by self-reporting methods. |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
|
Anxiety and Depression.
Tijdsspanne: The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
The hospital Anxiety and Depression Scale (HADS) will measure symptoms of anxiety and depression |
The change between the baseline screening and the evaluation at 1 month, 6 months and 12 months.
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- TRADITION
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .